Novem Group’s ASML ASML Stock Holding History

Novem Group’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$398K	Buy	+200	New	+$318K	0.04%	308

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Novem Group's ASML Position: Q2 2026 in Review

Novem Group reduced its ASML (ASML) stake by 23% in Q2 2026, selling an estimated $457K and leaving 950 shares worth $1.89M. The position accounts for 0.19% of the portfolio, ranked #103.

Novem Group first reported a position in ASML in Q4 2024 and has held it in 7 quarters since. 2,497 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Novem Group held 950 shares of ASML worth $1.89M as of Q2 2026.
Novem Group sold 287 ASML shares in Q2 2026, an estimated $457K.
ASML made up 0.19% of Novem Group's portfolio in Q2 2026, its #103 holding.
Novem Group first reported a position in ASML in Q4 2024 and has held it in 7 quarters since.
2,497 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.